www.fdanews.com/articles/179582-novartis-ultibro-breezhaler-reduces-copd-symptoms-improves-lung-function
Novartis’ Ultibro Breezhaler Reduces COPD Symptoms, Improves Lung Function
December 8, 2016
Novartis’ dual bronchodilator, Ultibro Breezhaler, showed improvements in lung function and a reduction in chronic obstructive pulmonary disease symptoms.
The study has provided further support to limit the use of inhaled steroid-containing therapies, the company said.
The combination device is approved for use in more than 90 countries. — Cynthia Jessup